Vimarsana
Biggest News Aggregation in the World

Page 6 - Aktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aktx Today - Breaking & Trending Today

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance NASDAQ AKTX opened at $0.21 on Tuesday. Akari Therapeutics has a 52 week low of $0.14 and a 52 week high of […]

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Akari Therapeutics stock opened at $0.21 on Tuesday. The company has a 50 day moving average price of $0.21 […]

Akari Therapeutics, Plc (NASDAQ:AKTX) Short Interest Update - Vimarsana News

Akari Therapeutics, Plc (NASDAQ:AKTX) Short Interest Update

Akari Therapeutics, Plc (NASDAQ:AKTX – Get Rating) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 111,800 shares, a decline of 62.3% from the April 15th total of 296,900 shares. Based on an average daily volume of 444,700 shares, the days-to-cover ratio is […]

Source: wkrb13.com
StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report published on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of AKTX opened at $0.18 on Monday. The firm has a market cap of $13.10 million, a P/E ratio of -0.50 […]

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $0.18 on Friday. The company has a market capitalization of $13.40 million, a PE ratio of […]